Judith Guasch group

"Biohybrid Hydrogels for Tumoroid Culture" ranks within the top 10% of most-viewed articles in Advanced Biology

Our review on "Biohybrid Hydrogels for Tumoroid Culture" has been recognized as a top viewed article (among the top 10%) in the peer-reviewed journal Advanced Biology (Wiley) among work published 2023.

Eduardo Pérez del Río receives an award for the best publications of 2020 by CIBER-BBN

Nanomol researcher Eduardo Pérez del Río has been awarded with one of the 4 prices for the best publications of 2020 of young researchers by CIBER-BBN.

ICMAB researcher Judith Guasch obtains "la Caixa" Foundation funding to advance in hydrogels for cancer research

Guasch's team's innovative work on hybrid hydrogels, enabling 3D cell cultures for cancer research applications, has been selected by the CaixaImpulse Innovation Programme to facilitate its introduction to the market.

Judith Guasch is awarded with a Ramón y Cajal grant #RYC

ICMAB researcher Judith Guasch has been granted with a Ramón y Cajal grant from the Spanish Ministry of Economy, Industry and Competitiveness in the branch of “Biomedicine”.

Judith Guasch, awarded with a leader position of a Max Planck Partner Group

The ICMAB researcher Judith Guaschhas been appointed Leader of a Max Planck Partner Group(Dynamic Biomimetics for Cancer Immunotherapy) in collaboration with the Max Planck Institute for Medical Research (Heidelberg, Germany). This position, started this same 2017, strengthens the collaboration of ICMAB with the Max Planck Society through the research that Judith is performing, which is based on the development of biomimetic lymph nodes to help improving novel adoptive cell therapies, specially those designed to treat cancer.